Acuta Capital Partners, LLC Annexon, Inc. Transaction History

Acuta Capital Partners, LLC

  • $122 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$22.0 - $35.01 $550,000 - $875,250
-25,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$20.81 - $30.55 $1.77 Million - $2.6 Million
-85,000 Reduced 77.27%
25,000 $626,000
Q3 2020

Nov 16, 2020
BUY
$17.5 - $30.23 $1.93 Million - $3.33 Million
110,000 New
110,000 $3.33 Million

Others Institutions Holding ANNX

# of Institutions
138
Shares Held
87.3M
Call Options Held
2.54M
Put Options Held
556K
View Full List

About Annexon, Inc.

ANNX Quotes by TradingView
  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $233M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email